Literature DB >> 8624975

Left atrial enlargement in healthy obese: prevalence and relation to left ventricular mass and diastolic function.

Z Sasson1, Y Rasooly, R Gupta, I Rasooly.   

Abstract

BACKGROUND: Left atrial (LA) enlargement has been reported in the obese. However, its prevalence in the healthy obese, clinical correlates and relation to left ventricular (LV) mass and diastolic function have been little investigated.
METHODS: Thirty-five consecutive, healthy, normotensive obese (body mass index greater than 28, mean +/- SD 34.2 +/- 2.3 kg/m2) and 35 nonobese subjects (body mass index 24.6 +/- 2.3 kg/m2) comparable in age and sex underwent echocardiographic measurements of LA posteroanterior (parasternal view), mediolateral and superoinferior (apical views) dimensions, aortic root diameter, LV mass and Doppler assessment of LV diastolic function. LA enlargement was defined as a posteroanterior dimension greater than 40 mm. A ratio of LA posteroanterior dimension to aortic root diameter greater than 1.4 was used as an index for disproportionate LA enlargement.
RESULTS: LA enlargement was more frequent in the obese than in the nonobese (37% versus 6%, P<0.0001). Similarity, disproportionate LA enlargement was more frequent in the obese (34% versus 6%, P<0.0001). LA posteroanterior dimension correlated well with body mass index (r=0.52, P<0.0001) and LV mass (r=0.56, P<0.0001), and weakly with blood pressure (r=0.28, P<0.02). There was no significant correlation with LV diastolic function, age or sex. In multivariate analysis (multiple r=0.61, P<0.0001), LA posteroanterior dimension correlated significantly only with mass (P<0.005), and the association with body mass index and blood pressure became nonsignificant. Similar results were obtained when LA posteroanterior dimension was replaced with mediolateral or superoinferior dimensions.
CONCLUSIONS: LA enlargement is frequent in the normotensive, otherwise healthy obese and correlates well with LV mass. It is not mediated through impairment of LV diastolic function, and likely reflects a physiological adaptation of the heart to the obese state. Further studies are needed to determine whether LA enlargement in the obese is associated with adverse long term outcome.

Entities:  

Mesh:

Year:  1996        PMID: 8624975

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  9 in total

1.  Exercise effects on cardiac size and left ventricular diastolic function: relationships to changes in fitness, fatness, blood pressure and insulin resistance.

Authors:  K J Stewart; P Ouyang; A C Bacher; S Lima; E P Shapiro
Journal:  Heart       Date:  2005-11-24       Impact factor: 5.994

2.  Influence of obstructive sleep apnea on left ventricular mass and global function: sleep apnea and myocardial performance index.

Authors:  Ercan Varol; Selahattin Akcay; Mehmet Ozaydin; Onder Ozturk; Sevim Sureyya Cerci; Unal Sahin
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

Review 3.  Effects of Obesity on Cardiovascular Hemodynamics, Cardiac Morphology, and Ventricular Function.

Authors:  Martin A Alpert; Jad Omran; Brian P Bostick
Journal:  Curr Obes Rep       Date:  2016-12

4.  Possible beneficial effect of olmesartan medoxomil on left atrial function in patients with hypertension : noninvasive assessment by acoustic quantification.

Authors:  Hui-Ping Gong; Wei Zhang; Li Li; Hong-Wei Tan; Zhi-Yong Ma; Xue-Zhen Zhong; Zhi-Hao Wang; Tao Song; Yun Zhang; Ming Zhong
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

5.  Long-term obesity promotes alterations in diastolic function induced by reduction of phospholamban phosphorylation at serine-16 without affecting calcium handling.

Authors:  Ana Paula Lima-Leopoldo; André S Leopoldo; Danielle C T da Silva; André F do Nascimento; Dijon H S de Campos; Renata A M Luvizotto; Adriana F de Deus; Paula P Freire; Alessandra Medeiros; Katashi Okoshi; Antonio C Cicogna
Journal:  J Appl Physiol (1985)       Date:  2014-06-26

Review 6.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

Review 7.  Cardiopulmonary Pathophysiological Aspects in the Context of COVID-19 and Obesity.

Authors:  Abdallah Fayssoil; Marie Charlotte De Carne De Carnavalet; Nicolas Mansencal; Frederic Lofaso; Benjamin Davido
Journal:  SN Compr Clin Med       Date:  2021-06-14

Review 8.  Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.

Authors:  O Asghar; U Alam; S A Hayat; R Aghamohammadzadeh; A M Heagerty; R A Malik
Journal:  Curr Cardiol Rev       Date:  2012-11

9.  Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography.

Authors:  Antoine Kossaify; Nayla Nicolas
Journal:  Clin Med Insights Cardiol       Date:  2013-02-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.